Skip to content

STADA Specialty Care

Our portfolio includes biosimilars for immunology, oncology, and ophthalmology indications, a nephrology product line, and a Parkinson’s franchise. Our specialty medicines account for approximately 20% of STADA’s sales, which reached an impressive EUR 3.80 billion in 2022, marking an 11% increase from the previous year.

As Europe’s fourth-largest supplier of consumer healthcare and generic medicines by sales, we are proud to serve patients in approximately 120 countries worldwide. Our team of 13,183 employees is dedicated to delivering innovative solutions that meet the evolving needs of patients and healthcare providers. Our Headquarters is located in Bad Vilbel, Germany.

For more information, please visit: www.stada.comSpecialty Pharmaceuticals | STADA

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.